Brief: Mimedx Epifix Receives Reimbursement Approval In Japan
Sept 12 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX EPIFIX® RECEIVES REIMBURSEMENT APPROVAL IN JAPAN
* COMPANY IS IN THE LAST STAGES OF PREPARING FOR FULL
PRODUCT
LAUNCH, ANTICIPATED IN THE FOURTH QUARTER
Source text for Eikon: ID:nGNXrFvBP
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates